AzTrials
AzTrials

Premature EjaculationGETUPNCT02378779

Consultations Reason for Genital, Urinary or Psychological Humans in General Practice

A study testing Questionary SF12 and PEDT (Premature Ejaculation Diagnostic Tool), Total attention and Humour in people with Premature Ejaculation, run by University Hospital, Brest at 23 sites in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Many male patients complain about their ejaculation: 21-30% of men aged between 18 and 59 have admitted suffering from a decrease in, or loss of control of, their ejaculation. The quality of life of patients and their partners is impaired compared to men not suffering from premature ejaculation. Read more about this study

Who is it for?
Ages 18 to 80 years, men only
Conditions the study is for
Premature Ejaculation
What is being tested?
Questionary SF12 and PEDT (Premature Ejaculation Diagnostic Tool), Total attention and Humour
Could I receive a placebo?
No, everyone receives an active treatment
How many people
132 participants
Where
23 sitesFrance
Study dates
22 Apr 2016to 22 Apr 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male patients overbetween 18 and 80 years old and
  • Patients consulting for a sexual, urogenital or psychological reason according to Interntational Classification of Primary Care (ICPC-2) will be included.

Who cannot join

  • Patients consulting for Aanother reason for visiting thethan urogenital pattern, sexual or psychological
  • Nonunderstanding of the French language
  • Patients with psychiatric disorders affecting judgement
  • Patient refusal to participate in the study

Trial locations and contacts

23 sites in 1 country.

23 sites in 1 country

France23 sites
  • Cabinet médical

    Ambert, 63600

  • Cabinet médical - 89 Bis Rue de la Calade

    Assas, 34820

  • Cabinet médical

    Augerolles, 63930

  • Cabinet médical

    Avermes, 0300

  • Cabinet médical - Esplanade Mitterrand 5

    Bellerive-sur-Allier, 03700

  • Cabinet de médecine générale

    Brest, 29200

  • Cabinet du 122 rue Paul Masson

    Brest, 29200

  • Cabinet médical Place J. London

    Brest, 29200

  • Cabinet médical

    Clarensac, 30870

  • Cabinet médical

    Fleury, 11560

  • Pôle universitaire de Lanmeur

    Lanmeur, 29620

  • Cabinet médical

    Le Mayet-de-Montagne, 03250

  • Cabinet médical

    Le Puy-en-Velay, 43000

  • Cabinet médical

    Lempdes-sur-Allagnon, 43410

  • Cabinet médical du 38 Bd 1848

    Narbonne, 11000

  • Cabinet de médecine générale

    Ondres, 40440

  • Cabinet de médecine générale

    Pont-de-Buis-lès-Quimerch

  • Cabinet médical du 5 Descente des Oliviers

    Restinclières, 34160

  • Cabinet médical

    Saint-Nicolas-du-Pélem, 22480

  • Groupe médical Tourren

    Saint-Vincent-de-Tyrosse, 40230

  • Cabinet de médecine générale

    Saubrigues, 40230

  • Cabinet médical

    Thézan Les Béziers, 34490

  • Cabinet médical - 39 rue Saint Philibert

    Trégunc, 29910

Other trials in France

About this study

Many male patients complain about their ejaculation: 21-30% of men aged between 18 and 59 have admitted suffering from a decrease in, or loss of control of, their ejaculation. The quality of life of patients and their partners is impaired compared to men not suffering from premature ejaculation. Economically, the impact of the disease are significant. In the year preceding the detection of premature ejaculation patients visit twice their physician. The majority of men interviewed anonymously, in their General Practitioner's ( GP's) waiting room, considered it important to talk with their GP about their sexual concerns. Almost half of them preferred that their GP initiate any discussions about sexuality. More than two thirds of the respondents would have liked their GP to signal his or her open-mindedness by directly addressing sexual topics during the consultation. In 2008 a qualitative study brought to the fore the strategies used by GPs to initiate the discussion on premature ejaculation . GPs who mentioned premature ejaculation with their patient described three attitude-related strategies and three investigative strategies.

Being tested
Questionary SF12 and PEDT (Premature Ejaculation Diagnostic Tool), Total attention, Humour, Take the drama out, Question about premature ejaculation
Keywords
Premature ejaculation, general practice, sexual dysfunction
Medical subject headings
Premature Ejaculation, Sexual Dysfunction, Physiological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Questionary SF12 and PEDT (Premature Ejaculation Diagnostic Tool)Other

    The SF-12 was designed to measure general health status from the patient's point of view (12 questions are asking to the patients) and the PEDT questionnaire is a self-assessment questionnaire to diagnose premature ejaculation (5 questions are asking to the patients).

  • Total attentionOther

    Total attention of the GP to approach the subject of premature ejaculation during all the consultation

  • HumourOther

    Use the humour to approach the subject of premature ejaculation

  • Take the drama outOther

    Take the drama out to approach the subject of premature ejaculation

  • Question about premature ejaculationOther

    Question about premature ejaculation during the GP consultation

  • Symptoms of premature ejaculationOther

    GP's observation about signs of premature ejaculation

  • Help to verbalizeOther

    Help for the patient to speak about premature ejaculation

Study groups in NCT02378779
Study groupRoleWhat they receive
Interventional GP : GP trainned in communication skillsOtherThe subjects have to answer to the questionary SF12 on pre and post consultation to evaluate the quality of life. He must so answer to the questionary PEDT. Then the interventional GP group must use one of the six strategies to approach the subject of premature ejaculation. There three strategies of attitude (Total attention, Humour, Take the drama out) and three investigative strategies (Question about premature ejaculation, Symptoms of premature ejaculation, Help to verbalize).
Receives: Other: Questionary SF12 and PEDT (Premature Ejaculation Diagnostic Tool); Other: Total attention; Other: Humour; Other: Take the drama out; Other: Question about premature ejaculation; Other: Symptoms of premature ejaculation; Other: Help to verbalize
Usual care : GP did not trainnd in communication skillsOtherThe subjects have to answer to the questionary SF12 on pre and post consultation to evaluate the quality of life. He must so answer to the questionary PEDT. This classical GP group make a classical consultation like each day without use any strategies to speak about
Receives: Other: Questionary SF12 and PEDT (Premature Ejaculation Diagnostic Tool)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The impact of training general practitioners in communication skills

    The impact of training general practitioners in communication skills on the rate of patients bringing up the topic of premature ejaculation with their GP. To measure the proportions of patients bringing up the topic of premature ejaculation with their GP, the GPs in the two groups were asked to fill in a questionnaire after the consultation on whether the topics tackled were genital, urinary or psychological. The aim of detailing the different topics broached was to avoid contamination bias in the control group.

    Measured: Day 0 - 4 weeks

Secondary outcomes (1)
  1. Evaluation of quality of life

    The quality of life will be evaluated with the SF-12 health assessment scale. The SF-12 was designed to measure general health status from the patient's point of view. The SF-12 includes 8 concepts commonly represented in health surveys: physical functioning, role functioning physical, bodily pain, general health, vitality, social functioning, role functioning emotional, and mental health.

    Measured: Day 0 - 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2015 (estimated)
  2. Study start22 Apr 2016
  3. Primary completion22 Apr 2018
  4. Study completion22 Apr 2018

Why it stopped: Multiple reminders were carried out but despite these measures, the GP has not enough participated .

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study is a multicenter trial. Patients will be followed either by GPs from the interventional group who trained in communication skills or by the control group who never participated. The distribution of general practitioners in the groups is done thanks random draw .
Masking
None (open label)
Enrolment
132 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02378779
Sponsor's protocol ID
GETUP
Acronym
GETUP
Status last verified
Oct 2020
First submitted
3 Feb 2015
Last updated
19 Oct 2020
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes: All collected data that underlie results in a publication

Publications

  • Barais M, Vaillant Roussel H, Costa D, Derriennic J, Pereira B, Cadier S. Premature ejaculation in primary care: communication strategies versus usual care for male patients consulting for a sexual, urogenital or psychological reason - GET UP: study protocol for a cluster randomised controlled trial. Trials. 2018 Nov 12;19(1):622. doi: 10.1186/s13063-018-2947-2.

    PubMed 30419940

Questions about this trial

What is this clinical trial studying?

A study testing Questionary SF12 and PEDT (Premature Ejaculation Diagnostic Tool), Total attention and Humour in people with Premature Ejaculation, run by University Hospital, Brest at 23 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 19 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 23 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Multiple reminders were carried out but despite these measures, the GP has not enough participated .). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The impact of training general practitioners in communication skills (time frame: Day 0 - 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02378779, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in